Search Results - "claisse, Guillaume"

Refine Results
  1. 1

    Predicting the dose of vancomycin in ICU patients receiving different types of RRT therapy: a model‐based meta‐analytic approach by Claisse, Guillaume, Zufferey, Paul J., Trone, Jane C., Maillard, Nicolas, Delavenne, Xavier, Laporte, Silvy, Ollier, Edouard

    Published in British journal of clinical pharmacology (01-06-2019)
    “…Aim Previous pharmacokinetic (PK) studies have proposed various dosing regimens for vancomycin in intensive care unit (ICU) patients undergoing renal…”
    Get full text
    Journal Article
  2. 2

    Relationship Between mean fluorescence intensity and C1q/C3d-fixing capacities of anti-hla antibodies by claisse, Guillaume, absi, Lena, cognasse, Fabrice, alamartine, Eric, mariat, Christophe, maillard, Nicolas

    Published in Human immunology (01-04-2017)
    “…Abstract Background Complement-binding assays are proposed to better stratify the risk of antibody-mediated rejection associated-graft failure. Despite…”
    Get full text
    Journal Article
  3. 3

    Relationship Between Plasmatic Metformin Concentration and Renal Replacement Therapy: A Multicenter Cohort Study by Demaretz, Lise, Claisse, Guillaume, Fanton-D’Andon, Cornélie, Crepet, Françoise, Herda, Adel, Marin, Clémence, Gonzalo, Philippe, Mariat, Christophe, Delavenne, Xavier, Launay, Manon

    Published in Therapeutic drug monitoring (01-12-2022)
    “…Metformin is the first-line treatment used for type 2 diabetes mellitus for more than 60 years. Metformin-associated lactic acidosis is the most serious…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Living Kidney Donor Evaluation by Claisse, Guillaume, Gaillard, François, Mariat, Christophe

    Published in Transplantation (01-12-2020)
    “…Long-term safety of living kidney donation (LKD), especially for young donors, has become a real matter of concern in the transplant community and may…”
    Get full text
    Journal Article
  6. 6

    Relevance of Anti-HLA Antibody Strength Underestimation in Single Antigen Bead Assay for Shared Eplets by Claisse, Guillaume, Devriese, Magali, Lion, Julien, Maillard, Nicolas, Caillat-Zucman, Sophie, Mooney, Nuala, Taupin, Jean Luc

    Published in Transplantation (01-12-2022)
    “…HLAs contain combinations of multiple eplets, sometimes shared between numerous HLA alleles. Some authors suggested that single antigen bead (SAB) assays may…”
    Get full text
    Journal Article
  7. 7

    P0654INTEREST OF SCREENING FOR CKD AFTER AKI IN ICU AND THE PLACE OF CYSTATIN C IN THIS POPULATION by Claisse, Guillaume, Maillard, Nicolas, Dinic, Miriana, Mariat, Christophe

    Published in Nephrology, dialysis, transplantation (01-06-2020)
    “…Abstract Background and Aims Acute Kidney Injury (AKI) is one of the most frequent complications in Intensive Care Unit (ICU). It’s now clearly established…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Repeat renal biopsy improves the Oxford classification-based prediction of immunoglobulin A nephropathy outcome by Jullien, Perrine, Laurent, Blandine, Berthoux, François, Masson, Ingrid, Dinic, Miriana, Claisse, Guillaume, Thibaudin, Damien, Mariat, Christophe, Alamartine, Eric, Maillard, Nicolas

    Published in Nephrology, dialysis, transplantation (01-07-2020)
    “…Abstract Background The prognosis of IgA nephropathy (IgAN) is very heterogeneous. Predicting the nature and the rate of the disease progression is crucial for…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Validation of the international IgA nephropathy prediction tool in a French cohort beyond 10 years after diagnosis by Bon, Grégoire, Jullien, Perrine, Masson, Ingrid, Sauron, Catherine, Dinic, Miriana, Claisse, Guillaume, Pelaez, Alicia, Thibaudin, Damien, Mohey, Hesham, Alamartine, Eric, Mariat, Christophe, Maillard, Nicolas

    Published in Nephrology, dialysis, transplantation (01-10-2023)
    “…ABSTRACT Introduction The International IgA Nephropathy Network developed a tool (IINN-PT) for predicting the risk of end-stage renal disease (ESRD) or a 50%…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20